References

 

All content containing the following references was taken from Before You Decide 2011 pamphlet by Care Net.

  1. Cunningham G, et al. Williams Obstetrics. 21st ed. New York: McGraw-Hill Publishers; 2001.
  2. Mayo Clinic. Fetal development: the first trimester. Available at: http://www.mayoclinic.com/health/prenatal-care/PR00112. Accessed March 7, 2011.
  3. Mayo Clinic. Week three: fertilization. Available at: http://www.mayoclinic.com/health/prenatal-care/PR00112. Accessed March 7, 2011.
  4. Larimore WL. Growing debate about the abortifacient effect of the birth control pill and the principle of the double effect. Journal Ethics and Medicine. January 2000;16(1):23-30. Updated October 1, 2004. Available at: http://www.epm.org/resources/2010/Feb/22/growing-debate-about-abortifacient-effect-birth-co/. Accessed March 16, 2011.
  5. Katz V, et al. Comprehensive Gynecology. 5th ed. Philadelphia: Mosby-Elsevier; 2007.
  6. Plan B One-Step Prescribing Information. Mechanism of action. Available at: http://planbonestep.com/pdf/PlanBOneStepFullProductInformation.pdf. Accessed on February 14, 2011.
  7. Plan B One-Step Prescribing Information. Dosage and administration. Available at: http://planbonestep.com/pdf/PlanBOneStepFullProductInformation.pdf. Accessed on February 14, 2011.
  8. Plan B One-Step Prescribing Information. Adverse reactions. Available at: http://planbonestep.com/pdf/PlanBOneStepFullProductInformation.pdf. Accessed on February 14, 2011.
  9. Plan B One-Step Prescribing Information. Contraindications. Available at: http://planbonestep.com/pdf/PlanBOneStepFullProductInformation.pdf. Accessed on February 14, 2011.
  10. Plan B One-Step Prescribing Information. Indications and usage. Available at: http://planbonestep.com/pdf/PlanBOneStepFullProductInformation.pdf. Accessed on February 14, 2011.
  11. Plan B One-Step Prescribing Information. Ectopic pregnancy. Available at: http://planbonestep.com/pdf/PlanBOneStepFullProductInformation.pdf. Accessed on February 14, 2011.
  12. Plan B One-Step Prescribing Information. Clinical studies. Available at: http://planbonestep.com/pdf/PlanBOneStepFullProductInformation.pdf. Accessed on February 14, 2011.
  13. American Congress of Obstetricians and Gynecologists. Emergency contraception. Practice Bulletin No. 112, May 2010.
  14. Plan B One-Step Prescribing Information. Available at: http://planbonestep.com/pdf/PlanBOneStepFullProductInformation.pdf. Accessed on February 14, 2011.
  15. Watson Pharma, Inc. ELLA – ulipristal acetate tablet. Available at: http://pi.watson.com/data_stream.asp?product_group=1699&p=pi&language=E. Accessed February 23, 2011.
  16. Harrison DJ, Mitroka JG. Defining reality: the potential role of pharmacists in assessing the impact of progesterone receptor modulators and misoprostol in reproductive health.  The Annals of Pharmacotherapy. Dec 21, 2010;45(1):115-9.
  17. Princeton University. The emergency contraception website. Available at: http://ec.princeton.edu/questions/ecsideeffects.html. Accessed February 14, 2011.
  18. U.S. Food and Drug Administration. Mifepristone questions and answers 4/17/2002. Available at: http://www.fda.gov/Drugs/DrugSafety/PostmarketDrug SafetyInformationforPatientsandProviders/ucm111354.htm. Accessed March4, 2011.
  19. U.S. Food and Drug Administration. Mifeprex medication guide. How should I take mifeprex? Available at:http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088643.pdf. Accessed February 13, 2011.
  20. U.S. Food and Drug Administration. Mifeprex package insert. Vaginal bleeding. Available at:http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/020687s013lbl.pdf. Accessed February 12. 2011.
  21. U.S. Food and Drug Administration. Mifeprex package insert. Infection and sepsis. Available at:http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/020687s013lbl.pdf. Accessed February 12. 2011.
  22. U.S. Food and Drug Administration. Mifeprex package insert: boxed warnings. Available at:http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/020687s013lbl.pdf. Accessed February 12. 2011.
  23. U.S. Food and Drug Administration. FDA issues public health advisory for mifepristone. Available at:http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2005/ucm108462.htm. Accessed March 20, 2011.
  24. U.S. Food and Drug Administration. Mifeprex package insert. Ectopic pregnancy. Available at:http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/020687s013lbl.pdf. Accessed February 12. 2011.
  25. Spitz IM, et al. Early pregnancy termination with mifepristone and misoprostol in the United States. N Engl J Med 1998;338(18):1241-7.
  26. Paul M, Lichtenberg S, Borgatta L, Grimes DA, Stubblefield PG, Creinin MD, eds. Management of Unintended and Abnormal Pregnancy: Comprehensive Abortion Care. UK:Wiley-Blackwell;2009.
  27. U.S. Food and Drug Administration. Mifeprex medication label. Available at: http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/020687s013lbl.pdf. Accessed February 12. 2011.
  28. Physician’s Desk Reference. Methotrexate. Concise monograph. Available at: http://www.pdr.net/drugpages/concisemonograph.aspx?concise=589. Accessed March 21, 2011.
  29. Physician’s Desk Reference. Cytotec (Misoprostol) Concise monograph. Available at: http://www.pdr.net/drugpages/concisemonograph.aspx?concise=1380. Accessed March 22, 2011.
  30. American Congress of Obstetricians and Gynecologists. Induced Abortion. ACOG Patient Education Pamphlet; November 2008.
  31. Rock J, Thompson J. TeLinde’s Operative Gynecology. 8th ed. Philadelphia: Lippincott-Raven; 1997.
  32. Stenchever MA, Droegemueller W, Herbst AL, Mischell D. Comprehensive Gynecology. 4th ed. St. Louis: Mosby; 2001.
  33. Fox MC, et al. Cervical preparation for second trimester surgical abortion prior to 20 weeks. Contraception 2007;76(6):486-95.
  34. Pasquini L, et al. Intracardiac injection of potassium chloride as method for feticide: experience from a single UK tertiary centre. BR J Obstet Gynaecol.2008;115(4):528-31.
  35. Thorp JM, Hartmann KE, Shadigian E. Long term physical and psychological health consequences of induced abortion: review of the evidence. Obstet Gynecol Surv. 2003;58(1):67-79.
  36. Guttmacher Institute. State policies in brief, abortion reporting requirements as of February 2011. Available at:http://www.guttmacher.org/statecenter/spibs/spib_ARR.pdf. Accessed February 23, 2011.
  37. American Congress of Obstetricians and Gynecologists. Antibiotic prophylaxis for gynecologic procedures. Practice Bulleting No. 104; May 2009.
  38. American Congress of Obstetricians and Gynecologists. Dilatation & Curettage. Patient Education Pamphlet; December 2005.
  39. American Congress of Obstetricians and Gynecologists. Pelvic Inflammatory Disease. Patient Education Pamphlet; April 2010.
  40. American Congress of Obstetricians and Gynecologists. Management of alloimmunization during pregnancy. Practice Bulletin No. 75; August 2006.
  41. Guttmacher Institute. Facts on induced abortion in the United States. August 2011. Available at http://www.guttmacher.org/pubs/fb_induced_abortion.html. Accessed June 20, 2012.
  42. Pazol K, et al. Centers for Disease Control and Prevention. Abortion Surveillance – United States, 2007. Morbidity and Mortality Weekly Report. Surveillance Summaries. February 25, 2011;60(01):1-39.
  43. Moreau D, Kaminski M, Ancel PY, Bouyer J, et al. Previous induced abortions and the risk of very preterm delivery: results of the EPIPAGE study Br J Obstet Gynaecol. 2005;112(4):430-7.
  44. Ancel PY, Lelong N, Papiernik E, Saurel-Cubizolles MJ, Kaminski M. History of induced abortion as a risk factor for preterm birth in European countries: results of EUROPOP survey. Hum Reprod. 2004;19(3):734-40.
  45. Stang P, Hammond AO, Bauman P. Induced abortion increases the risk of very preterm delivery, results from a large perinatal database. Fertility Sterility.September 2005;S159.
  46. Brown TS, Adera T, Masho SW. Previous abortion and the risk of low birth weight and preterm births. J Epidemiol Community Health.  2008;62:16-22.
  47. Freak-Poli R, Chan W, Gaeme J, Street J. Previous abortion and risk of preterm birth: a population study. J Matern Fetal Med Jan. 2009;22(1):1-7.
  48. Rooney B, Calhoun B. Induced abortion and risk of later premature births. J Am Phys Surg. 2003;8(2):46-9.
  49. Behrman R, Stith B. preterm birth: causes, consequences, and prevention. Institute of Medicine of the National Academy of Sciences; 2006.
  50. National Cancer Institute. Pregnancy and breast cancer risk. Available at: http://www.cancer.gov/cancertopics/factsheet/Risk/pregnancy. Accessed February 14, 2011.
  51. Hsieh C, et al. Dleivery of premature newborns and maternal breast cancer risk. Lancet. 1999.
  52. Russo J, et al. Developmental, molecular and cellular basis of human breast cancer. J Natl Cancer Inst Monogr. 2000;27:17-37.
  53. Brind J. Induced abortion as an independent risk factor for breast cancer: a critical review of recent studies based on prospective data. J Am Phys Surg. Winter 2005;10(4).
  54. Carroll P. The breast cancer epidemic: modeling and forecasts based on abortion and other risk factors. J Am Phys Surg.  2007;12(3).
  55. Royal College of Psychiatrists. Position statement on women’s mental health in relation to induced abortion. March, 14 2008.
  56. Cougle JR, et al. Depression associated with abortion and childbirth: a long-term analysis of the NLSY cohort. Med Sci Monit. 2003;9(4):105-12.
  57. Fergusson DM, et al. Abortion in young women and subsequent mental health. J Child Psychol Psychiatry. 2006;47(1):16-24.
  58. Pedersen W. Abortion and depression: a population-based longitudinal study of young women. Scand J Public Health. 2008;36(4):424-8.
  59. Rees DI, Sabia JJ. The relationship between abortion and depression: new evidence from the Fragile Families and Child Wellbeing Study. Med Sci Monit.2007;13(10):430-6.
  60. Coleman P, Reardon D, Rue V. Prior history of induced abortion in relation to substance use during subsequent pregnancies carried to term. Am J Obstst Gynecol. 2002;187:1673-8.
  61. Coleman P, et al. Substance use among pregnant women in the contest of previous reproductive loss and desire for current pregnancy. Br J Health Psychol.2005;10:255-68
  62. Coleman PK. Resolution of unwanted pregnancy during adolescence through abortion versus childbirth: individual and family predictors and psychological consequences. J Youth Adolesc. 2006;35:903-11.
  63. Pedersen W. Childbirth, abortion and subsequent substance use in young women: a population-based longitudinal study.  Addiction. 2007 December; 102(12):1971-8.
  64. Reardon DC, Coleman PK, Cougle J. Substance use associated with prior history of abortion and unintended birth: a national cross sectional cohort study.  Am J Drug Alcohol Abuse.  2004;26:369-83.
  65. Rue VM, et al. Induced abortion and traumatic stress: a preliminary comparison of American Russian women. Med Sci Monit.  2004;10:5-16.
  66. Reardon DC, Shuping MW, et al. Deaths associated with abortion compared to childbirth: a review of old and new data and the medical and legal implications. J Contemp Health Law Policy.  2004;20(2):279-327.
  67. Gissler M, et al. Injury deaths, suicides and homicides associated with pregnancy; Eur J Public Health.  2005;15(5):459-63.
  68. Shadigian EM, et al. Pregnancy-associated death: a qualitative systematic review of homicide and suicide.  Obstet Gynecol Surv 2005;60(3):183.
  69. Cougle J, Reardon DC, Coleman PK. Generalized anxiety associated with unintended pregnancy: a cohort study of the 1995 National Survey of Family Growth.  J Anxiety Disord.  2005;19(10):137-42.
  70. Broen AN, Moum T, Bodtker AS, Ekeberg O. Psychological impact on women of miscarriage versus induced abortion: a 2-year follow-up study. Psychosom Med.2004;66(2):265-71.
  71. Broen AN, Moum T, Bodtker AS, Ekeberg O. The course of mental health after miscarriage and induced abortion: a longitudinal, five-year follow-up study. BMC Med. 2005;3:18.
  72. Coleman PK, Rue VM, Coyle CT. Induced abortion and intimate relationship quality in the Chicago Health and Social Life Survey. Public Health. April 2009;123(4):331-8.
  73. Coleman PK, et al. Predictors and correlates of abortion in the Fragile Families and Well-Being Study: paternal behavior, substance use, and partner violence. Int J Ment Health Addict. July 2009;7(3):405-22.
  74. National Council for Adoption. Adoption awareness training program; 2009.
  75. Mosby’s Medical Dictionary, 8th edition. Copyright 2009, Elsevier. Available at: http://medical-dictionary.thefreedictionary.com/abortifacient. Accessed March 17, 2001.
  76. The American Heritage Medical Dictionary. Copyright 2007, 2004 by Houghton Mifflin Company. Available at: http://medical-dictionary.thefreedictionary.com/abortion. Accessed March 17, 2011.
  77. Dorland’s Medical Dictionary for Health Consumers. Gestation period. Copyright 2007 by Saunders, an imprint of Elsevier, Inc. Available at: http://medical-dictionary.thefreedictionary.com/period. Accessed March 14, 2011.
  78. The American Heritage Dictionary of the English Language, Fourth Edition. Copyright 2000 by Houghton Mifflin Company. Updated 2009. Available at:http://www.thefreedictionary.com/implantation. Accessed March 16, 2011.
  79. U.S. Food & Drug Administration. Truthful prescription drug advertising and promotion: the prescriber’s role – recognize and report. Common violations. April 2010. Available at:http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Surveilance/PrescriptionDrugAdvertisingandPromotionalLabeling/UCM209847.pdf. Accessed March 16, 2011.

Additional References

  1. Cates JR, Herndon NL, Schulz S L, Darroch JE. (2004). Our voices, our lives, our futures: Youth and sexually transmitted diseases. Chapel Hill, NC: University of North Carolina at Chapel Hill School of Journalism and Mass Communication. Available at: http://www.ashastd.org/std-sti/std-statistics.html. Accessed July 31, 2012.
  2. Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance 2010. Atlanta: U.S. Department of Health and Human Services; 2011. Available at: http://www.cdc.gov/std/stats10/default.htm. Accessed July 31, 2012
  3. Macklon, N.S., J.P.M. Geraedts, and B.C.J.M. Fauser, “Conception to ongoing pregnancy: the ‘black box’ of early pregnancy loss.” Human Reproduction Update2002. Available at: http://humupd.oxfordjournals.org/content/8/4/333.full.pdf+html. Accessed July 31, 2012.
  4. Wilcox, A.J., C.R. Weinberg, J.F. O’Connor, D.D. Baird, J.P. Schlatterer, R.E. Canfield, E.G. Armstrong, and B.C. Nisula, “Incidence of early loss of pregnancy.”NEJM Jul 1988. Available at: http://content.nejm.org/cgi/content/abstract/319/4/189. Accessed July 31, 2012.
  5. Strahan, Thomas W. “Portraits of Post-Abortive Father Devastated by the Abortion Experience.” Association for Interdisciplinary Research in Values and Social Change. 1994:7(3).
  6. A Review of Federal Law and NCAA Rules Impacting Treatment of Pregnant and Parenting Student-Athletes at http://www.ncaa.org/sites/default/files/Model%2BPolicy%2BLegal%2BReview.pdf.